Microbial signatures in the blood could offer new avenue for liquid biopsies to detect cancer
CDC
Researchers developed machine learning models that, in early-stage testing, could identify and distinguish between different types of cancer.
Suscribirse a:
Enviar comentarios (Atom)
.png)
No hay comentarios:
Publicar un comentario